Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype
about
Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control studyRoles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy.Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy.Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy.Pregnancy represses induction of efflux transporters in livers of type I diabetic mice.Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum.Maternal cholestasis during pregnancy programs metabolic disease in offspring.Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.Hepatic bile acids and bile acid-related gene expression in pregnant and lactating rats.Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic PathologiesA model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders.A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy.Promoter DNA methylation of farnesoid X receptor and pregnane X receptor modulates the intrahepatic cholestasis of pregnancy phenotype.Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application.Management of intrahepatic cholestasis of pregnancy.The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.Differential regulation of intestinal efflux transporters by pregnancy in mice.Two cases of first onset intrahepatic cholestasis of pregnancy associated with moderate ovarian hyperstimulation syndrome after IVF treatment and review of the literature.Pregnancy and bile acid disorders.Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.Transient receptor potential canonical 5 channels plays an essential role in hepatic dyslipidemia associated with cholestasis.Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.Liver: Links between hepatobiliary diseases in and beyond pregnancy.Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients.An application of target profiling analyses in the hepatotoxicity assessment of herbal medicines: comparative characteristic fingerprint and bile acid profiling of Senecio vulgaris L. and Senecio scandens Buch.-Ham.Bile acids evoke placental inflammation by activating Gpbar1/NF-κB pathway in intrahepatic cholestasis of pregnancy.Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy
P2860
Q24297171-AD8AD2A5-0344-4E56-8552-2FAE10570392Q28294560-D98E4DAA-A639-4AC5-9AD7-84650D92E195Q31149202-5CF10086-859A-494A-8372-3DECB4769442Q34155271-6B5EBE24-4DA3-4FE3-BF2D-06CBCC6F9591Q34324898-616EBD19-FB12-4096-AF8E-DEFEE7AB6190Q35023748-BAE61498-18CB-4C96-84DF-D3372D008880Q36095783-24CE81C3-9F8E-4979-BD28-E4CF25A823B6Q36816962-06608B8A-E689-4E69-9BD4-1FAD39B0924CQ36908093-29F8F258-C98B-424E-9EEC-84499A5CDB3AQ36966996-526F721A-C563-4F54-A319-354F8118B0ADQ36970872-05E819EF-2DDC-421A-BD46-2215564D0F6DQ37132885-44029357-2267-4210-AC89-01E045D704C6Q37210911-F530231B-2998-4FF3-82FB-CFBD9C9C509FQ37305377-CE4D52D0-524C-4661-AA97-A5D6DFBE4C91Q37460903-8BD6D78B-5DAB-4DE6-A692-CB0F5070DFC6Q37539016-AC7580BF-EF7D-4D64-A860-9030A4842547Q38541491-A5F1D569-63E6-461D-A988-46CABB9F8584Q38575049-3D44880C-87A8-4248-B417-020289D41165Q38943288-28A6B95B-E45A-4684-A04A-C6F209FFB069Q39044340-76F84BF0-5792-4BE7-8E32-3338C54EF421Q39187973-B3E1C938-AB0B-4660-8B39-A55FC1AF8613Q39267976-FADD722E-220D-4585-9A99-B34ADCDA546CQ39408782-E5F8A4D6-8F02-4EF7-9973-50F9EEDA658DQ41780489-F1BCB057-443D-4501-A03D-FD4CB9924E66Q42697966-1746F455-DB96-4693-9325-C719271E6F04Q44283220-1F9DC463-B85D-4A32-8C02-2185C5C77043Q44459930-13DDEF8D-D5C1-46EF-A3AE-160C39D5DFD2Q46836939-5755DDF5-4073-4802-AACC-91852B178D7CQ51648079-9DFDC083-A0C3-4924-9BE2-022B497AC8CFQ57389439-B51EFAC3-870E-4709-913F-E536BE6D5B73
P2860
Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@ast
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@en
type
label
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@ast
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@en
prefLabel
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@ast
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@en
P2093
P2860
P356
P1433
P1476
Intrahepatic cholestasis of pr ...... ing in a cholestatic phenotype
@en
P2093
Anita Lövgren-Sandblom
Catherine Williamson
Clare Selden
Georgia Papacleovoulou
Hanns-Ulrich Marschall
Jenny Chambers
Malcolm G Parker
Mehreen Tahir
Myrddin Rees
Nurul Akmal Jamaludin
P2860
P304
P356
10.1002/HEP.26055
P407
P577
2013-01-08T00:00:00Z